daohang fenxiangbox searchbox qikanlogonew daohangnew searchboxnew navrightzone footerzone paper

A Self-Assembled Copper-Selenocysteine Nanoparticle for Enhanced Chemodynamic Therapy via Oxidative Stress Amplification AITranslate

Fuzhou University; Fuzhou University; Fujian Medical University Union Hospital; Minjiang University; Fuzhou University; Fujian Medical University Union Hospital
AITranslate
Publisher: ACS
Share Citation Information Add to Favorites

    Scan to share on WeChat or Moments

Use WeChat scan.
Share with WeChat friends or Moments

Abstract AITranslate

Chemodynamic therapy (CDT) as a catalytic anticancer strategy utilizes transition metal ions to initiate the Fenton reaction to produce high levels of cytotoxic hydroxyl radicals(·OH) in situ. Nevertheless, current existing CDTs are normally restricted by the high levels of existing antioxidant molecules and/or enzymes, such as glutathione (GSH) and thioredoxin reductase (TrxR), in a tumor internal environment, which could suppress CDT via ·OH depletion. Herein, to enhance ·OH-induced cellular damage by CDT, a self-assembled copper-selenocysteine nanoparticles (Cu-SeC NPs) was fabricated through a one-pot process. In our design, once Cu-SeC NPs were endocytosed by tumor cells, Cu2+ was reduced to Cu+ by cellular GSH, promoting in situ Fenton-like reactions to trigger ·OH rapid production in cells as well as the depletion of GSH. Furthermore, the gradually released selenocysteine can inhibit TrxR activity to weaken the protection of antioxidant systems and provide a favorable microenvironment for CDT. As a result, both paths synergistically resulted in massive reactive oxygen species (ROS) accumulation and amplified oxidative stress in tumor sites for enhanced CDT. As a new intelligent anticancer nanoplatform, Cu-SeC NPs exhibit synergistic antitumor effects with negligible systemic toxicity. Thus, the proposed strategy provides a new avenue for further development of progressive therapeutic systems.

KeyWords AITranslate

No data

Basic Information:

DOI:https://doi.org/10.1021/acsmaterialslett.2c01024

Chinese Library Classification Number:

Citation Information:

Chemodynamic therapy (CDT) as a catalytic anticancer strategy utilizes transition metal ions to initiate the Fenton reaction to produce high levels of cytotoxic hydroxyl radicals(·OH) in situ. Nevertheless, current existing CDTs are normally restricted by the high levels of existing antioxidant molecules and/or enzymes, such as glutathione (GSH) and thioredoxin reductase (TrxR), in a tumor internal environment, which could suppress CDT via ·OH depletion. Herein, to enhance ·OH-induced cellular damage by CDT, a self-assembled copper-selenocysteine nanoparticles (Cu-SeC NPs) was fabricated through a one-pot process. In our design, once Cu-SeC NPs were endocytosed by tumor cells, Cu2+ was reduced to Cu+ by cellular GSH, promoting in situ Fenton-like reactions to trigger ·OH rapid production in cells as well as the depletion of GSH. Furthermore, the gradually released selenocysteine can inhibit TrxR activity to weaken the protection of antioxidant systems and provide a favorable microenvironment for CDT. As a result, both paths synergistically resulted in massive reactive oxygen species (ROS) accumulation and amplified oxidative stress in tumor sites for enhanced CDT. As a new intelligent anticancer nanoplatform, Cu-SeC NPs exhibit synergistic antitumor effects with negligible systemic toxicity. Thus, the proposed strategy provides a new avenue for further development of progressive therapeutic systems.

quote

GB/T 7714-2015 [1] Ziyi Chen, Xin Wang, Yihang Ding, et al. ACS Materials Letters, 2023(5). DOI:10.1021/acsmaterialslett.2c01024.
MLA [1] Ziyi Chen, et al., ACS Materials Letters, no. 5, 2023, https://doi.org/10.1021/acsmaterialslett.2c01024.
APA [1] Ziyi Chen, Xin Wang, Yihang Ding, Chao Xing, Chunhua Lu, & Xiankun Tu. (2023). ACS Materials Letters(5). https://doi.org/10.1021/acsmaterialslett.2c01024
IEEE [1] Ziyi Chen, Xin Wang, Yihang Ding, Chao Xing, Chunhua Lu, and Xiankun Tu, ACS Materials Letters, no. 5, 2023, doi: 10.1021/acsmaterialslett.2c01024.